Onealfa


Combined with:

Loxonin
Mucosta
Prednisolone
Predonine

Indications and Reactions:

Role Indications Reactions
Secondary
Osteoporosis 21.1%
Rheumatoid Arthritis 17.6%
Hypertension 13.8%
Drug Use For Unknown Indication 13.4%
Juvenile Arthritis 5.4%
Gastritis 4.6%
Depression 3.4%
Rash 3.1%
Constipation 2.7%
Dementia Alzheimer's Type 1.9%
Bronchitis Chronic 1.5%
Iga Nephropathy 1.5%
Insomnia 1.5%
Product Used For Unknown Indication 1.5%
Anorexia 1.1%
Dementia 1.1%
Diabetes Mellitus 1.1%
Dyslipidaemia 1.1%
Hepatitis B 1.1%
Hyperuricaemia 1.1%
Laryngeal Oedema 8.3%
Osteomyelitis 8.3%
Renal Impairment 8.3%
Tuberculous Pleurisy 8.3%
Agranulocytosis 6.3%
Bile Duct Stone 6.3%
Mixed Hepatocellular-cholestatic Injury 6.3%
Multiple Myeloma 6.3%
Upper Respiratory Tract Inflammation 6.3%
Acute Myocardial Infarction 4.2%
Erythema Multiforme 4.2%
Interstitial Lung Disease 4.2%
Malaise 4.2%
Pemphigoid 4.2%
Vasculitis 4.2%
Anosmia 2.1%
Blood Creatine Phosphokinase Increased 2.1%
Blood Potassium Decreased 2.1%
Blood Pressure Decreased 2.1%
Diverticulum Intestinal 2.1%
Concomitant
Rheumatoid Arthritis 20.3%
Osteoporosis 14.8%
Product Used For Unknown Indication 11.6%
Hypertension 10.9%
Prophylaxis 9.7%
Gastritis 3.7%
Drug Use For Unknown Indication 3.2%
Constipation 3.1%
Diabetes Mellitus 2.6%
Insomnia 2.5%
Juvenile Arthritis 2.4%
Hyperlipidaemia 2.1%
Hyperphosphataemia 1.9%
Crohn's Disease 1.8%
Myelodysplastic Syndrome 1.8%
Hepatitis C 1.7%
Pain 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.5%
Multiple Myeloma 1.5%
Parkinson's Disease 1.3%
Vomiting 9.0%
White Blood Cell Count Decreased 8.5%
Femur Fracture 7.6%
Pneumonia 7.3%
Pyrexia 6.2%
Sepsis 5.6%
White Blood Cell Count Increased 5.6%
Rash 5.4%
Renal Impairment 5.4%
Interstitial Lung Disease 4.5%
Anaemia 3.9%
Pneumocystis Jiroveci Pneumonia 3.9%
Upper Respiratory Tract Inflammation 3.9%
Nausea 3.7%
Platelet Count Decreased 3.7%
Spinal Compression Fracture 3.4%
Hypoglycaemia 3.1%
Liver Disorder 3.1%
Osteomyelitis 3.1%
Somnolence 3.1%

Drug Data